Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 4,448 | 20,221 | 8,583 | 4,089 | 13,617 |
| Gross Profit | 4,448 | 20,221 | 8,583 | 4,089 | 13,617 |
| Operating Expenses | 16,587 | 17,728 | 19,348 | 22,801 | 25,506 |
| Operating Income | -12,139 | 2,493 | -10,765 | -18,712 | -11,889 |
| Interest Expense | 2,046 | 1,560 | 138 | 0 | 0 |
| Other Income | 12,383 | 128 | -435 | 293 | 249 |
| Pre-tax Income | -1,802 | 1,061 | -11,338 | -18,419 | -11,640 |
| Net Income Continuous | -1,802 | 1,061 | -11,338 | -18,419 | -11,640 |
| Net Income | $-1,802 | $1,061 | $-11,338 | $-18,419 | $-11,640 |
| EPS Basic Total Ops | -0.46 | 0.30 | -3.10 | -5.38 | -3.52 |
| EPS Basic Continuous Ops | -0.46 | 0.28 | -3.07 | -5.47 | -3.52 |
| EPS Diluted Total Ops | -0.46 | 0.30 | -3.10 | -5.38 | -3.52 |
| EPS Diluted Continuous Ops | -0.46 | 0.28 | -3.07 | -5.47 | -3.52 |
| EPS Diluted Before Non-Recurring Items | -0.46 | 0.30 | -3.10 | -5.50 | -3.50 |
| EBITDA(a) | $-14,901 | $5,506 | $-9,963 | $-18,053 | $-10,949 |